Chemiphar Maintains Operating Profit Despite Some Losses
Japanese Firm Marks The Second Profitable Quarter In A Row
After past challenges caused by reimbursement drug price cuts imposed by the Japanese government, Chemiphar has managed to keep its operating profits in the black in the second quarter of its 2024 financial year.
